NovaBridge Biosciences (ADR) share price logo

NovaBridge Biosciences (ADR)

NASDAQ: NBP

$1.86

+0.02

(+1.09%)

Live

as on

NovaBridge Biosciences (ADR) Stock Performance

as on August 13, 2026 at 3:10 am IST

  • Day's Low

    Day's High

    $1.80
    $1.88
    downward going graph

    3.23%

    Downside

    1.08%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

NovaBridge Biosciences (ADR) share price movements today

Previous Close
$1.84
Open
$1.82
Volume
232.2K
Day's Low - High
$1.80 - $1.88

NovaBridge Biosciences (ADR) Historical Returns

1 Month Return
-3.16 %
3 Month Return
-10.68 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

NovaBridge Biosciences (ADR) Stock Fundamentals & Key Indicators

Check NovaBridge Biosciences (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$204.7M

EPS (TTM)

-0.94

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-40.89%

NovaBridge Biosciences (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NovaBridge Biosciences (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NovaBridge Biosciences (ADR) image
NovaBridge Biosciences (ADR)
NA$204.7MNANA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$44.4B758.25%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$132.8B171.88%28.935.00%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$83.2B31.09%19.4227.87%0.45999999999999996%

Indian Investors' Interest in NovaBridge Biosciences (ADR) Stock

Search interest for NovaBridge Biosciences (ADR) Stock has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-61% versus previous 30 day period

NovaBridge Biosciences (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-30
1
71
-
-
-
-
237
-
Gross Profit
-30
-19
71
-
-
-
-
237
-
Operating Income
-179
-90
-124
-12
-13
-5
-7
-8
-72
EBITDA
-173
-84
-118
-6
-
-5
-7
-8
-
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
0
0
-
-
0
0
Income Before Tax
-392
-69
-58
-20
-10
-3
-5
-6
-72
Income Tax Expense
-149
-
6
-
-
-84
-
-384
-
Net Income
-243
20
-33
-20
-9
-3
-5
-6
-30
Net Profit Margin
798.92%
1835.25%
-46.13%
0.00%
0.00%
0.00%
0.00%
-2.87%
0.00%

NovaBridge Biosciences (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
11
53
30
1,542
13
-1
0
-
-
Gross Profit
11
53
30
1,542
6
-1
0
-
0
Operating Income
-273
-455
-1,464
155
-2,071
-366
-511
-375
-13
EBITDA
-279
-431
-197
168
-2,057
-356
-344
-373
-13
Interest Expense
0
1
0
0
-
0
0
-
-
Depreciation
-
-
-
-
5
1
1
0
0
Income Before Tax
-290
-416
-1,451
483
-2,332
-973
-1,465
-362
-12
Income Tax Expense
-
1
-
12
0
-5
-1,258
-
-
Net Income
-298
-402
-1,448
470
-366
-138
-205
-162
-6
Net Profit Margin
-2647.41%
-749.02%
-4826.77%
30.53%
-2648.70%
9044.58%
-32674.02%
0.00%
0.00%

NovaBridge Biosciences (ADR) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
20
180
-143
-9
-22
-13
-48
-30
-72
Operating Cash Flow
-
-
8
-10
-
-
13
-14
-14
Investing Cash Flow
-
-
-
-
-
-
0
-
-
Financing Cash Flow
-
-
-
-
-
-
433
-3
-3
Change in Cash
-
-
-72
-11
-
-
446
-17
-17

NovaBridge Biosciences (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-402
-1,451
470
-2,331
-2,507
-208
-362
-88
Operating Cash Flow
-280
-867
433
-973
-1,102
-72
-384
-20
Investing Cash Flow
9
212
-201
-727
458
-107
-992
104
Financing Cash Flow
1,479
152
3,440
593
42
-8
-2
57
Change in Cash
1,268
-487
3,565
-1,235
-212
-151
-1,706
142

Global Institutional Holdings in NovaBridge Biosciences (ADR)

Funds
Holdings
Morgan Stanley - Brokerage Accounts
3.32%
Candriam Luxembourg S.C.A.
0.98%
Citadel Advisors Llc
0.14%
Siren, L.L.C.
2.59%
AIHC Capital Management Limited
1.96%
See all

Insights on NovaBridge Biosciences (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, NBP stock has moved up by 12.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 585.4% return, outperforming this stock by 613.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 483.0% return, outperforming this stock by 535.2%

About NovaBridge Biosciences (ADR)

NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its product pipeline comprises givastomig, a potential CLDN18.2 bispecific antibody, which is in phase 2 clinical trial combination with nivolumab and chemotherapy for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies; Phase 1b clinical trial in combination with nivolumab and chemotherapy in first-line gastric cancer. The company also develops VIS-101, VEGF-A × ANG-2 bispecific biologics in Phase 2 clinical trial to treat wet age-related macular degeneration and other retinal diseases, including diabetic macular edema; ragistomag, which is in Phase 1clinical trial for multiple solid tumors. It has a licensing agreement with AskGene to develop and commercialize VIS-101; collaborations with Bristol Myers Squibb for the development of givastomig; and license and collaboration agreement with AbbVie Ireland Unlimited Company for the development and commercialization of lemzoparlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.
OrganisationNovaBridge Biosciences (ADR)
Headquarters2440 Research Boulevard, Rockville, MD, United States, 20850
IndustryBiotechnology
CEODr. Srishti Gupta M.D.
E-voting on sharesClick here to vote

Key Management of NovaBridge Biosciences (ADR)

Name

Title

Mr. Sean Wuxiong Cao M.B.A., Ph.D.

Chief Business Development Officer & Director

Mr. Mark Hagler

President & Chief Commercial Officer

Mr. Tyler Ehler

Senior Director of Investor Relations

Ms. Liwei Lin

General Counsel & Board Secretary

Dr. Cong Xu M.D., Ph.D.

Senior VP and Head of R&D Center of Excellence

Dr. Phillip Dennis M.D., Ph.D.

Chief Medical Officer

Mr. Wei Fu

Executive Chairman

Mr. Ming Lei

Chief Financial Officer

Dr. Srishti Gupta M.D.

CEO & Director

FAQs

What is NovaBridge Biosciences (ADR) share price today?

NovaBridge Biosciences (ADR) share price today is $1.86 as on . NovaBridge Biosciences (ADR) share today touched a day high of $1.88 and a low of $1.80.

What is the 52 week high and 52 week low for NovaBridge Biosciences (ADR) share?

NovaBridge Biosciences (ADR) share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . NovaBridge Biosciences (ADR) stock price today i.e. is trending at $1.86,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is NovaBridge Biosciences (ADR)'s market capitalisation today?

NovaBridge Biosciences (ADR) market capitalisation is $0.00T as on .

How to invest in NovaBridge Biosciences (ADR) Stock (NBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NovaBridge Biosciences (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NovaBridge Biosciences (ADR) Shares that will get you 0.8065 shares as per NovaBridge Biosciences (ADR) share price of $1.86 per share as on August 12, 2026 at 9:40 pm IST.

What is the minimum amount required to buy NovaBridge Biosciences (ADR) Stock (NBP) from India?

Indian investors can start investing in NovaBridge Biosciences (ADR) (NBP) shares with as little as ₹95.32 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.20 in NovaBridge Biosciences (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on NovaBridge Biosciences (ADR) share’s latest price of $1.86 as on August 12, 2026 at 9:40 pm IST, you will get 5.3763 shares of NovaBridge Biosciences (ADR). Learn more about fractional shares .